What Clockwork Bio Builds
Clockwork Bio is an AI-native biotechnology startup developing a high-throughput, "lab-in-the-loop" data engine intended to automate pre-clinical drug discovery, starting with oncology. In GeekWire's March 23, 2026 cohort report, Plug and Play Seattle summarized the startup as building a data engine for AI-enabled drug discovery by applying artificial intelligence at every step of the Experimental Biology Loop. Its official landing page at clockworkbio.ai states its mission succinctly as "Engineering a world without cancer."
Technically, Clockwork Bio's platform pairs active learning systems with AI-based phenotyping to push cells in vitro into diseased states and back again, generating structured experimental data to map underlying disease biology and surface therapeutic targets at scale. Researchers and investors looking up the company should carefully verify the domain: Seattle's AI drug discovery company operates at clockworkbio.ai, whereas clockwork.bio belongs to an unrelated fractional COO and lab-space infrastructure consultancy (Clockwork Bio LLC) serving Boston, New York, San Diego, San Francisco, and Europe, and Clockwork.io is an unrelated GPU infrastructure software vendor.
- Experimental Biology Loop Automation: Applies AI and active learning iteratively across experimental design, wet-lab execution, and phenotypic readout.
- Initial Therapeutic Focus: Pre-clinical oncology target discovery using in vitro cellular state modeling.
- Domain Disambiguation: Official website is clockworkbio.ai—separate from fractional operations consultancy clockwork.bio and Clockwork.io.

| Field | Verified Record (As of Nov 19, 2026) |
|---|---|
| Company | Clockwork Bio |
| Official Website | clockworkbio.ai (distinct from unrelated consultancy clockwork.bio and GPU vendor Clockwork.io) |
| Washington HQ | Seattle, WA (CEO Shane Lewin based in Seattle; listed as Seattle by Plug and Play and GeekWire) |
| Other WA Footprint | Plug and Play Seattle workspace access at UW CoMotion Labs (Seattle); Co-founder & CTO Nick Peterson based in San Francisco, CA |
| Founded | 2026 (official launch announced March 2026) |
| Founders / Leadership | Shane (John) Lewin (Co-founder & CEO), Nick Peterson, PhD (Co-founder & CTO) |
| Stage | Accelerator / Raising Seed (Plug and Play Seattle Batch 3, March–June 2026) |
| Announced Funding | Not publicly disclosed |
| Team Size | Not publicly disclosed |
| Primary Ecosystem Ties | Plug and Play Seattle (Batch 3 cohort, UW CoMotion Labs access, UW Kane Hall showcase) |
Washington Footprint and Leadership
Clockwork Bio is listed as a Seattle company in Plug and Play Seattle's Batch 3 cohort and GeekWire's March 23, 2026 coverage, reflecting Co-founder and CEO Shane (John) Lewin's Seattle base and the company's participation in Plug and Play's Seattle program with office access inside the University of Washington's CoMotion Labs and cohort showcase programming at UW Kane Hall. The founding team spans two West Coast biotech hubs, with Co-founder and CTO Nick Peterson, PhD based in San Francisco, California.
Both co-founders come directly from senior AI and scientific data roles inside pharmaceutical company GSK (GlaxoSmithKline). Prior to launching Clockwork Bio in March 2026, Shane Lewin served as a VP and leader of AI and Machine Learning at GSK, following earlier engineering and product roles at Microsoft, Netflix, and startups, and holds an MS in Computational and Mathematical Engineering from Stanford University. Nick Peterson, PhD is a mathematician and AI/data leader who previously led GSK's internal Onyx discovery data platform.

Products, Users, and Public Traction
Clockwork Bio is building its lab-in-the-loop discovery engine for internal pre-clinical oncology programs and potential biopharmaceutical R&D partners seeking systematic target discovery. Because the company was announced in March 2026, its public technical and commercial footprint remains deliberately compact.
As observed on November 19, 2026, clockworkbio.ai presents a minimal corporate landing page with navigation for Home, Team, and Blog alongside an inquiry email (info@clockworkbio.ai) and a 2026 copyright notice. No named pharmaceutical collaborators, published peer-reviewed benchmarks, clinical asset timelines, or employee headcounts have been publicly disclosed.
Funding, Stage, and Place in Washington's AI Landscape
Clockwork Bio entered Plug and Play Seattle's 12-week Batch 3 accelerator in March 2026 alongside nine other startups (nine of the ten based in Seattle) for a program running through mid-June 2026. Public event and accelerator records place the company in the accelerator / seed-fundraising stage, with no closed institutional funding amount or venture investor syndicate publicly disclosed as of November 19, 2026.
Within Washington's AI landscape, Clockwork Bio extends Seattle's deep computational biology and life-sciences talent pool—anchored around UW, Fred Hutch, and local big-tech ML alumni—into closed-loop wet-lab data generation. Alongside fellow Plug and Play Seattle life-sciences participant Polybiomics (Batch 2), Clockwork Bio reflects growing investor and accelerator focus on proprietary experimental data engines rather than purely in-silico model wrappers.
Related Washington AI Profiles & Tygart Media Context
- Polybiomics — Seattle AI Profile (AI Live-Cell Analysis & Biotech)
- MediScan AI — Seattle AI Profile (Healthcare & Med-Legal AI)
- GLACIS — Seattle AI Profile (Verifiable AI Governance & Trust)
- The Factory Is a Chat Window
Verified Primary Sources
- Clockwork Bio Official Website
- GeekWire — Plug and Play Seattle Batch 3 Cohort (Mar 23, 2026)
- Plug and Play Seattle
Get The Signal
What we actually ran, what it measured, and what it means for a restoration shop — every week, including the flops.

Leave a Reply